Tirofiban | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tirofiban
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Tirofiban

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 3 USDMF, 1 EU WC, 2 NDC API, 10 Listed Suppliers, $ API Reference Price

13 API Suppliers
3 USDMF
1 EU WC
2 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 10 FDA Orange Book, 1 Europe, 1 Canada, 2 Australia, 3 South Africa, 5 Listed Dossiers

22 FDF Dossiers
10 FDA Orange Book
1 Europe
1 Canada
2 Australia
3 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INJECTION - EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)

SOLUTION;INJECTION - EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)

RELATED EXCIPIENT COMPANIES

4 Actylis

4 Actylis

EXCIPIENTS BY APPLICATIONS

2 Parenteral, 2 Controlled & Modified Release

2 Parenteral
2 Controlled & Modified Release

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 13 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices

1 Finished Drug Prices

MARKET PLACE

3 FDF Dossiers

3 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

15 Others

15 Others

$ API Ref.Price (USD/KG) : 168,689 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 2Iroko Cardio (UK) Ltd.

02 2OptumInsight (Canada) Inc.

filter Patent Reset all filters

4 All

01 22052073

02 22234364

filter Product Reset all filters

4 All

01 4Tirofiban Hydrochloride

filter Dosage Reset all filters

4 All

01 2Liquid

02 2Liquid (concentrate for dilution)

filter Exp Date Reset all filters

4 All

01 22011-09-23

02 22016-10-23

Product Main Page

01

OptumInsight (Canada) Inc.

Tirofiban

BioAsia

Not Confirmed

OptumInsight (Canada) Inc.

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-10-23

Date Granted : 2000-02-08

Brand Name : AGGRASTAT

Patent Number : 2234364

Filing Date : 1996-10-23

Strength per Unit : 0.25mg / ml as tirofiban hydrochloride

Dosage Form : Liquid (concentrate for dilution)

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2016-10-23

Date Granted : 2000-02-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Iroko Cardio (UK) Ltd.

Tirofiban

BioAsia

Not Confirmed

Iroko Cardio (UK) Ltd.

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-09-23

Date Granted : 1998-05-26

Brand Name : AGGRASTAT

Patent Number : 2052073

Filing Date : 1991-09-23

Strength per Unit : 0.25mg / ml as tirofiban hydrochloride

Dosage Form : Liquid (concentrate for dilution)

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2011-09-23

Date Granted : 1998-05-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

OptumInsight (Canada) Inc.

Tirofiban

BioAsia

Not Confirmed

OptumInsight (Canada) Inc.

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-10-23

Date Granted : 2000-02-08

Brand Name : AGGRASTAT

Patent Number : 2234364

Filing Date : 1996-10-23

Strength per Unit : 0.05mg/ml tirofiban free base

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2016-10-23

Date Granted : 2000-02-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Iroko Cardio (UK) Ltd.

Tirofiban

BioAsia

Not Confirmed

Iroko Cardio (UK) Ltd.

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-09-23

Date Granted : 1998-05-26

Brand Name : AGGRASTAT

Patent Number : 2052073

Filing Date : 1991-09-23

Strength per Unit : 0.05mg/ml tirofiban free base

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2011-09-23

Date Granted : 1998-05-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!